The next frontier: Global leadership in biopharma Lakshmipriya Nair Jul 10, 2024 Cutting-edge research, future-ready talent, next-gen infrastructure, judicious investments and strategic collaborations are…
US FDA accepts biologics license application from Lupin for pegfilgrastim biosimilar EP News Bureau Jun 2, 2021 This BLA expands the company's oncology portfolio
‘Lupin has gained significant momentum towards development of biosimilar products with primary… Lakshmipriya Nair Dec 4, 2019 Lupin Biotech, with a new-age R&D facility in Pune, is developing and commercialising biosimilars globally. The successful…
